Dan Rosenbaum
Chief Executive Officer bei Kaydence Pharma USA
Profil
Daniel Harris Rosenbaum is currently the Chief Executive Officer at Kaydence Pharma USA. Prior to this, he was the Chief Executive Officer at NattoPharma ASA from 2015 to 2018.
He also worked as the General Manager-Nutraceuticals & Pharmaceutical at FMC Corp.
Mr. Rosenbaum completed his undergraduate degree at Cornell University and earned an MBA from Tuck School of Business at Dartmouth.
Aktive Positionen von Dan Rosenbaum
Unternehmen | Position | Beginn |
---|---|---|
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Kaydence Pharma USA operates as a pharmaceutical company. It offers vitamins, dietary supplement, and therapy to help patients prevent and reverse vascular diseases. The company is headquartered in East Brunswick, NJ. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Dan Rosenbaum
Unternehmen | Position | Ende |
---|---|---|
NATTOPHARMA ASA | Chief Executive Officer | 10.02.2018 |
FMC CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Dan Rosenbaum
Cornell University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FMC CORPORATION | Process Industries |
Private Unternehmen | 2 |
---|---|
NattoPharma ASA
NattoPharma ASA Pharmaceuticals: MajorHealth Technology NattoPharma ASA engages in the manufacture and sale of nutritional and pharmaceutical products. It offers vitamin K2 under the product brand MenaQ7. The company was founded by Frode Marc Bohan on November 4, 2004 and is headquartered in Oslo, Norway. | Health Technology |
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Kaydence Pharma USA operates as a pharmaceutical company. It offers vitamins, dietary supplement, and therapy to help patients prevent and reverse vascular diseases. The company is headquartered in East Brunswick, NJ. | Health Technology |